Industry Context — Common BS Fingerprints in Medical Devices, Pharma & Biotech
MOVANTIK
(https://movantik.com) 📸 Data Snapshot: May 24, 2026Analyze the raw signals below. How would a machine score this business’s credibility?
Here are the exact signals captured from up to six pages of the site — the same raw inputs the evaluation engine analyzed. They are grouped by signal type so you can weigh each the way the machine does.
🏗️ Semantic Structure — heading hierarchy & page identity (Info Density · Commodity Fingerprint)
HOMEPAGE (https://movantik.com)
NAV_HEADER_REPEATED (https://movantik.com/hcp/)
NAV_HEADER_HEADING_REPEATED_BODY (https://movantik.com/about/)
NAV_HEADER_HEADING_REPEATED_BODY (https://movantik.com/burden-of-oic/)
📝 The Narrative — clean text per page (Info Density · Semantic Coherence)
HOMEPAGE · THIN (https://movantik.com)
When opioid constipation slows you down, [H1] MOVANTIK gets you moving. [IMG: Number 1 Prescribed Oral Treatment of its kind] [H3] If you’re taking opioids and are constipated, don’t suffer in silence. Find out if MOVANTIK is right for youSame-day relief is possible.Find out howSave with MOVANTIKReferences: 1. MOVANTIK® (naloxegol). Prescribing information. Valinor Pharma, LLC; 2023. 2. Data on file. Prescription data. Valinor Pharma, LLC; 2023.
SUB-PAGE · THIN (https://movantik.com/hcp/)
For patients experiencing constipation from opioids for chronic non-cancer pain [H1] Anticipate OIC.Treat with confidence. [IMG: Number 1 Prescribed Oral Treatment of its kind] Is it possible your patients are suffering silently from OIC?References: 1. MOVANTIK® (naloxegol). Prescribing information. Valinor Pharma, LLC; 2023. 2. Data on file. Prescription data. Valinor Pharma, LLC; 2023.
SUB-PAGE · THIN (https://movantik.com/about/)
About MOVANTIK [H1] Rapid response with MOVANTIK [H2] In adults with chronic non-cancer pain, MOVANTIK 25 mg was shown to be effective for OIC in 2 clinical studies.1,2 In these studies, MOVANTIK worked quickly, often within 6-12 hours of the first dose1 [IMG: MOVANTIK in the AM may lead to Bowel movement in the PM] References: 1. MOVANTIK® (naloxegol). Prescribing information. Valinor Pharma, LLC; 2023. 2. Chey WD, Webster L, Sostek M, Lappalainen J, Barker PN, Tack J. Naloxegol for opioid-induced constipation in patients with noncancer pain. N Engl J Med. 2014;370(25):2387-2396.
SUB-PAGE (https://movantik.com/burden-of-oic/)
Burden of OICSuffering from opioid-induced constipation? [H1] You’re not alone.OIC is prevalent—yetundertreated. [H3] Don’t bear the burden of OIC alone – relief can begin with a conversation1,* [IMG: chart] [IMG: chart] *In an analysis of a multinational longitudinal study of 493 patients with chronic non-cancer pain and clinician-identified, patient-confirmed OIC.1†Constipation treatments included OTC laxatives (stool softeners, osmotics, stimulants, salines, and rectal options), prescription laxatives, and behavioral therapies (fiber supplements, increased fluids and exercise, and dietary changes). 29% of patients in the study reported “much benefit” from constipation treatments.1OTC treatment is usually not enough6References: 1. Coyne KS, LoCasale RJ, Datto CJ, Sexton CC, Yeomans K, Tack J. Opioid-induced constipation in patients with chronic noncancer pain in the USA, Canada, Germany, and the UK: descriptive analysis of baseline patient-reported outcomes and retrospective chart review. Clinicoecon Outcomes Res. 2014;6:269-281. 2. Bell TJ, Panchal SJ, Miaskowski C, et al. The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE 1). Pain Med. 2009;10:35-42. 3. Abramowitz L, Beziaud N, Labreze L. Prevalence and impact of constipation and bowel dysfunction induced by strong opioids: a cross-sectional survey of 520 patients with cancer pain: DYONISOS study. J Med Econ. 2013;16(2):1423-1433. 4. Kalso E, Edwards JE, Moore RA, et al. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain. 2004;112:372-380. 5. Crockett SD, Greer KB, Heidelbaugh JJ, et al. American Gastroenterological Association Institute Clinical Guidelines Committee. Gastroenterology. 2019;156:218-226. 6. Brock C, Olesen SS, Olesen AE, Frøkjaer JB, Andresen T, Drewes AM. Opioid-induced bowel dysfunction: pathophysiology and management. Drugs. 2012;72(14):1847-1865.
🛡️ Trust Signals — reviews, proof links, trust-theatre flag (Trust & Proof)
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 0 | 0 |
| /hcp/ | 0 | 0 |
| /about/ | 0 | 0 |
| /burden-of-oic/ | 2 | 0 |
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps (Identity & Authority)
Your Diagnosis
Before revealing the machine’s verdict, predict the BS score for each signal. Higher = more BS (more fluff, less verifiable substance). Drag each slider, then submit to compare your judgment against the engine.
Stuck? Reveal the heuristic lens — how the deterministic page-auditor reads each signal (no AI, pure pattern rules)
These are the structural rules a local, deterministic auditor applies — the same lens you can use to judge each signal. They describe what to look for, not this company’s result.
Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.
Pull the main entities out of the H1, then check whether they actually recur through the body. A page that announces one thing and then talks about another drifts. Headings with no real sentences underneath read as pseudo-substance.
Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.
Look at how much sentence length varies. Natural writing varies its rhythm; templated or mass-produced copy is statistically uniform. Very low variation reads as commodity content — unless unique named entities break the pattern.
Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
Want to apply this lens yourself? The free BS Indicator Chrome extension runs these heuristic checks live on any page. Bear in mind it is a single-page, deterministic tool — it relies only on pattern rules for the page in front of it and does not perform the cross-page semantic correlation this audit uses, so its readout is a starting lens, not the full verdict.
Based on 784 businesses audited.
MOVANTIK has 15.7 points less BS than the average for Medical Devices, Pharma & Biotech.
Medical Devices, Pharma & Biotech BS: MOVANTIK (movantik.com)
This is a rare case of a ‘marketing-first’ appearance that actually possesses the necessary receipts. While the slogans are generic pharma-speak, the granular clinical data and bibliographic rigor result in a very low BS score of 25.
To further lower the BS score, the site should implement Medication and Organization schema to solidify its digital identity. The 2014 study citations, while foundational, should be supplemented with more recent real-world evidence from 2024 or 2025 to avoid appearing stale. Replacing slogan-only H1 tags with headers that include the ‘Number 1 Prescribed’ claim would increase heading substance. Finally, linking reference numbers directly to DOI URLs would provide a seamless proof path for healthcare professionals.
The site perfectly matches the Pharma & Biotech category, specifically focusing on naloxegol for Opioid-Induced Constipation (OIC). The presence of heavy regulatory language, mandatory Important Safety Information (ISI), and clinical trial citations confirms a high-fidelity industry alignment.
“The score of 25 is driven primarily by the high Information Density and low Semantic Drift. The Commodity Fingerprint (6) and Identity (4) pillars provided the only significant point accumulation due to the templated nature of pharma compliance and the lack of technical schema implementation.”
This training module utilizes a snapshot of public data from MOVANTIK, captured on May 24, 2026, to demonstrate how machine logic evaluates different types of business narratives.
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to compare human intuition against machine-generated evaluations.
Notice to MOVANTIK: This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results provided by 1EuroSEO are intended as professional feedback to help improve any website’s machine-readability and authority signals. The 1EuroSEO BS Detection Tool is a free tool, and anyone can test any company to see how their content is interpreted by AI models.
Any company can use the insights for free and improve its voice by comparing it to industry clichés or competitors. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://movantik.com to view the most current version of its content and learn from the source what this company is about and what it offers.